Treatment of hereditary angioedema due to C1 inhibitor deficiency with Icatibant, a selective bradykinin B2 receptor antagonist: a safety perspective

被引：0

|

作者：

Bork, K.

机构：

来源：

ALLERGY | 2008年 / 63卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

97

引用

收藏

页码：47 / 47

页数：1

相关论文

共 50 条

[1] Icatibant, a Selective Bradykinin B2 Receptor Antagonist Used in Hereditary Angioedema Due to C1 Inhibitor Deficiency
Bork, K.
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (02) : AB165 - AB165
[2] Safety Evaluation of Icatibant, a Selective Bradykinin B2 Receptor Antagonist Used in Hereditary Angioedema Due to C1 Inhibitor Deficiency
Staubach, P.
Bork, K.
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : S100 - S100
[3] A case series about the treatment of hereditary angioedema due to C1 inhibitor deficiency with icatibant, a selective bradykinin B2 receptor antagonist
Bork, K.
[J]. ALLERGY, 2010, 65 : 455 - 455
[4] Acquired angioedema due to C1 inhibitor deficiency treated with icatibant, a selective bradykinin B2 receptor antagonist
Bork, K.
[J]. ALLERGY, 2011, 66 : 109 - 109
[5] Icatibant, a Selective Bradykinin-B2 Receptor Antagonist, in Acquired Angioedema Due to C1 Inhibitor Deficiency
Bork, K.
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB100 - AB100
[6] Treatment of hereditary angioedema with normal C1-inhibitor with icatibant, a selective bradykinin B2 receptor antagonist
Bork, K.
[J]. ALLERGY, 2011, 66 : 427 - 428
[7] Treatment for hereditary angioedema with the bradykinin (B2) receptor antagonist Icatibant (JE 049)
Rosenkranz, B
Meng, G
Knolle, J
Bork, K
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 : 166 - 167
[8] Treatment of patients with acute attacks of hereditary angioedema due to C1-INH deficiency with the bradykinin B2 receptor-antagonist Icatibant
Farkas, H.
Varga, L.
Szeplaki, G.
Temesszentandrasi, G.
Jakab, L.
Fekete, B.
Fust, G.
Karadi, L.
[J]. ALLERGY, 2008, 63 : 474 - 475
[9] The efficacy and safety of Icatibant, a selective bradykinin B2 receptor antagonist, for treating the symptoms of hereditary angioedema attacks
Cicardi, M.
[J]. ALLERGY, 2008, 63 : 474 - 474
[10] Icatibant, a new bradykinin B2 receptor antagonist, for hereditary angioedema attacks
Reshef, A.
Liebovich, I.
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (02) : S102 - S102

← 1 2 3 4 5 →